Viveca Odlind

No ORCID on file · 5 papers in corpus
observational 2005
The impact of age and intrauterine contraception on the clinical course of pelvic inflammatory disease
Gynecologic and obstetric investigation ·doi:10.1159/000088751

BACKGROUND: The aim of the study was to investigate the clinical course of pelvic inflammatory disease (PID) and factors that could predict failed conservative treatment of PID. Additionally, the study aimed to examine the role of age and i…

review 2002
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Acta obstetricia et gynecologica Scandinavica ·doi:10.1034/j.1600-0412.2002.810603.x

BACKGROUND: Recent studies have indicated that the risk of thromboembolic disease (VTE) in users of combined oral contraceptive pills (COCs) varies not only with estrogen dose, but also with the progestogen in pills with the same estrogen d…

rct 1997
Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year
Acta obstetricia et gynecologica Scandinavica ·doi:10.3109/00016349709047827

OBJECTIVE: To investigate the clinical effects especially with regard to histopathology and bleeding patterns by levonorgestrel (5- or 10 microg/24 h) released from an intrauterine system (IUS) in combination with estradiol valerate (2 mg) …

1997
P-128. Regulation of vascular endothelial growth factor expression in human endometrium by steroids: in-vitro and in-vivo studies
·doi:10.1093/humrep/12.suppl_2.180-b

Abstracts of the 13th Annual Meeting of the ESHRE, Edinburgh 1997 significantly increased (P < 0.05) in Norplant-treated endometrium following RU486 administration.Conclusion: Endometrium exposed to Norplant® and antiprogestogen displayed a…

nonrandomized-trial 1979
Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone
Contraception ·doi:10.1016/s0010-7824(79)80032-3

The study was made to evaluate the effect upon the ovarian steroid pattern during treatment with subcutaneously implanted silastic rods containing norethindrone. Four rods, each containing 37 mg norethindrone (NET), were implanted subcutane…